UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C

Molecular psychiatry, 2012-08, Vol.17 (8), p.781-789

2012

Volltextzugriff (PDF)

Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment

Molecules (Basel, Switzerland), 2021-02, Vol.26 (5), p.1294

2021

Volltextzugriff (PDF)

Novel Prodiginine Derivatives Demonstrate Bioactivities on Plants, Nematodes, and Fungi

Frontiers in plant science, 2020-10, Vol.11, p.579807-579807

2020

Volltextzugriff (PDF)

The Golgi stacking protein GRASP55 is targeted by the natural compound prodigiosin

Cell communication and signaling, 2023-10, Vol.21 (1), p.1-275, Article 275

2023

Volltextzugriff (PDF)

Production of tailored hydroxylated prodiginine showing combinatorial activity with rhamnolipids against plant-parasitic nematodes

Frontiers in microbiology, 2023-05, Vol.14, p.1151882

2023

Volltextzugriff (PDF)

A colourimetric high-throughput screening system for directed evolution of prodigiosin ligase PigC

Chemical communications (Cambridge, England), 2020-08, Vol.56 (61), p.8631-8634

2020

Volltextzugriff (PDF)

Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa‐2b/ribavirin

Alimentary Pharmacology & Therapeutics (Suppl), 2013-07, Vol.38 (1), p.16-27

2013

Volltextzugriff (PDF)

Long-term clearance of hepatitis C virus following interferon [alpha]-2b or peginterferon [alpha]-2b, alone or in combination with ribavirin

Journal of viral hepatitis, 2013-08, Vol.20 (8), p.524

2013

Volltextzugriff (PDF)

Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin

Journal of viral hepatitis, 2013-08, Vol.20 (8), p.524-529

2013

Volltextzugriff (PDF)

Understanding substrate binding and the role of gatekeeping residues in PigC access tunnels

Chemical communications (Cambridge, England), 2021-03, Vol.57 (21), p.2681-2684

2021

Volltextzugriff (PDF)

KnowVolution of prodigiosin ligase PigC towards condensation of short-chain prodiginines

Catalysis science & technology, 2021-04, Vol.11 (8), p.285-2815

2021

Volltextzugriff (PDF)

1366 HIGH SUSTAINED VIROLOGIC RESPONSE (SVR) AMONG GENOTYPE 1 PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN RE-TREATED WITH BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2A/RIBAVIRIN

Journal of hepatology, 2011-03, Vol.54, p.S541-S542

2011

Volltextzugriff (PDF)

New Prodigiosin Derivatives Obtained by Mutasynthesis in Pseudomonas putida

ACS synthetic biology, 2017-09, Vol.6 (9), p.1757-1765

2017

Volltextzugriff (PDF)

Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial

Journal of viral hepatitis, 2015-07, Vol.22 (7), p.596-606

2015

Volltextzugriff (PDF)

1100 DIRECT INHIBITION OF NS3/4A WITH BOCEPREVIR DOES NOT INCREASE INDUCTION OF ISG: AN ANALYSIS OF THE PIVOTAL BOCEPREVIR TRIALS (SPRINT-2/RESPOND-2)

Journal of hepatology, 2012-04, Vol.56, p.S433-S433

2012

Volltextzugriff (PDF)

821 INTERFERON (IFN)-FREE ALISPORIVIR (ALV) HAS A BETTER OVERALL SAFETY PROFILE COMPARED TO IFN-CONTAINING TREATMENT: A POOLED ANALYSIS OF THE ALV DEVELOPMENT PROGRAM

Journal of hepatology, 2013-04, Vol.58, p.S336-S337

2013

Volltextzugriff (PDF)

Condensing Enzymes from Pseudoalteromonadaceae for Prodiginine Synthesis

Advanced synthesis & catalysis, 2019-06, Vol.361 (11), p.2659-2667

2019

Volltextzugriff (PDF)

Optimized prodigiosin production with Pseudomonas putida KT2440 using parallelized noninvasive online monitoring

Biotechnology progress, 2022-05, Vol.38 (3), p.e3245-n/a

2022

Volltextzugriff (PDF)

409 PROJECTING THE LONG-TERM CLINICAL IMPACT OF BOCEPREVIR IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE-1 WHO FAILED PRIOR TREATMENT WITH PEGINTERFERON/RIBAVIRIN

Journal of hepatology, 2011-03, Vol.54, p.S164-S164

2011

Volltextzugriff (PDF)

1194 SUSTAINED VIROLOGIC RESPONSE AND BOCEPREVIR RESISTANCE-ASSOCIATED VARIANTS OBSERVED IN PATIENTS INFECTED WITH HCV GENOTPYPE 1A/1B WHEN TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN

Journal of hepatology, 2011-03, Vol.54, p.S471-S472

2011

Volltextzugriff (PDF)

418 UTILITY OF HISTORICAL DATA COMPARED TO LEAD-IN RESPONSE IN PREDICTING SUSTAINED VIROLOGIC RESPONSE IN NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN RE-TREATED WITH BOCEPREVIR+PEGINTERFERON ALFA-2B/RIBAVIRIN (P/R)

Journal of hepatology, 2011-03, Vol.54, p.S168-S169

2011

Volltextzugriff (PDF)

Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion

Gastroenterology (New York, N.Y. 1943), 1995-02, Vol.108 (2), p.463-469

1995

Volltextzugriff (PDF)

2014 IMPROVED INFLAMMATORY ACTIVITY WITH LOW-DOSE PEGINTRON (PEG) MAINTENANCE THERAPY IN PRIOR NONRESPONDERS WITH METAVIR FIBROSIS SCORES (MFS) OF F2/F3: FINAL RESULTS FROM THE EPIC3 PROGRAM

Journal of hepatology, 2010-04, Vol.52, p.S469-S470

2010

Volltextzugriff (PDF)

Hepatic free radical production after cold storage: Kupffer cell-dependent and -independent mechanisms in rats

Gastroenterology (New York, N.Y. 1943), 1995, Vol.108 (4), p.1167-1175

1995

Volltextzugriff (PDF)

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia

Journal of hepatology, 2006-01, Vol.44 (1), p.97-103

2006

Volltextzugriff (PDF)

1 – 25 von 749

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(657)
Mit Volltextzugriff
(611)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(413)
Life Sciences & Biomedicine
(327)
Humans
(292)
Biological And Medical Sciences
(168)
Male
(165)
Female
(142)
Medical Sciences
(125)
Animals
(100)
Middle Aged
(99)
Adult
(95)
Aged
(67)
Neurosciences & Neurology
(64)
Physical Sciences
(61)
Cardiovascular System & Cardiology
(60)
Clinical Neurology
(49)
Biochemistry & Molecular Biology
(48)
Fundamental And Applied Biological Sciences. Psychology
(47)
Risk Factors
(47)
Neurology
(43)
Technology
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(30)
Stroke
(23)
German Medical Science
(18)
Neurology
(18)
Circulation
(15)
Gastroenterology
(15)
The Journal Of Biological Chemistry
(14)
The New England Journal Of Medicine
(14)
Hepatology
(13)
Bioinformatics
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C

Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment

Novel Prodiginine Derivatives Demonstrate Bioactivities on Plants, Nematodes, and Fungi

The Golgi stacking protein GRASP55 is targeted by the natural compound prodigiosin

Production of tailored hydroxylated prodiginine showing combinatorial activity with rhamnolipids against plant-parasitic nematodes

A colourimetric high-throughput screening system for directed evolution of prodigiosin ligase PigC

Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa‐2b/ribavirin

Long-term clearance of hepatitis C virus following interferon [alpha]-2b or peginterferon [alpha]-2b, alone or in combination with ribavirin

Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin

Understanding substrate binding and the role of gatekeeping residues in PigC access tunnels

KnowVolution of prodigiosin ligase PigC towards condensation of short-chain prodiginines

1366 HIGH SUSTAINED VIROLOGIC RESPONSE (SVR) AMONG GENOTYPE 1 PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN RE-TREATED WITH BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2A/RIBAVIRIN

New Prodigiosin Derivatives Obtained by Mutasynthesis in Pseudomonas putida

Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial

1100 DIRECT INHIBITION OF NS3/4A WITH BOCEPREVIR DOES NOT INCREASE INDUCTION OF ISG: AN ANALYSIS OF THE PIVOTAL BOCEPREVIR TRIALS (SPRINT-2/RESPOND-2)

821 INTERFERON (IFN)-FREE ALISPORIVIR (ALV) HAS A BETTER OVERALL SAFETY PROFILE COMPARED TO IFN-CONTAINING TREATMENT: A POOLED ANALYSIS OF THE ALV DEVELOPMENT PROGRAM

Condensing Enzymes from Pseudoalteromonadaceae for Prodiginine Synthesis

Optimized prodigiosin production with Pseudomonas putida KT2440 using parallelized noninvasive online monitoring

409 PROJECTING THE LONG-TERM CLINICAL IMPACT OF BOCEPREVIR IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE-1 WHO FAILED PRIOR TREATMENT WITH PEGINTERFERON/RIBAVIRIN

1194 SUSTAINED VIROLOGIC RESPONSE AND BOCEPREVIR RESISTANCE-ASSOCIATED VARIANTS OBSERVED IN PATIENTS INFECTED WITH HCV GENOTPYPE 1A/1B WHEN TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN

418 UTILITY OF HISTORICAL DATA COMPARED TO LEAD-IN RESPONSE IN PREDICTING SUSTAINED VIROLOGIC RESPONSE IN NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN RE-TREATED WITH BOCEPREVIR+PEGINTERFERON ALFA-2B/RIBAVIRIN (P/R)

Endotoxin-stimulated nitric oxide production increases injury and reduces rat liver chemiluminescence during reperfusion

2014 IMPROVED INFLAMMATORY ACTIVITY WITH LOW-DOSE PEGINTRON (PEG) MAINTENANCE THERAPY IN PRIOR NONRESPONDERS WITH METAVIR FIBROSIS SCORES (MFS) OF F2/F3: FINAL RESULTS FROM THE EPIC3 PROGRAM

Hepatic free radical production after cold storage: Kupffer cell-dependent and -independent mechanisms in rats

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia

Suchergebnisse filtern